← Leaderboards
Jeffrey Galinkin
Children'S Hospital Of Philadelphia
$51,201
Attributed
$51,201
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $36.2K · FY2005–07$50K$37.5K$25K$12.5K$0
'05
'06
'07
Funding mix
By agency
NIH$51,201 · 4
By mechanism
M01$51,201 · 4
Top collaborators
No co-investigators on record.
Most similar at Children'S Hospital Of Philadelphia
Same institution · by research overlap
- Jeffrey H Silber$32,280,141
- Kathryn G Commons$6,280,807
- Babette S Zemel$12,389,104
- Itzhak Nissim$5,665,517
- Anne E Kazak$10,869,046
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchClinical Trial Phase IAnesthesia ComplicationPharmacokineticsPreschool Child (1-5)RadioimmunoassayHuman SubjectHuman Therapy EvaluationBehavioral /Social Science Research TagInhalation Drug AdministrationBehavior TestAnalgesiaChild BehaviorTympanoplastyFentanylPainPharmaceutical PreparationsPharmacokinetic ModelResearch PersonnelResourcesSamplingSerumSourceSpecimen
Grant awards (5)
THE SINGLE AND MULTIDOSE PHARMACOKINETICS OF KETOROLAC IN INFANTS$10,742
M01 · FY2007 · RR · contact PI
THE SINGLE AND MULTIDOSE PHARMACOKINETICS OF KETOROLAC IN INFANTS$36,185
M01 · FY2006 · RR · contact PI
THE SINGLE AND MULTIDOSE PHARMACOKINETICS OF KETOROLAC IN INFANTS$3,714
M01 · FY2005 · RR
EFFECT OF NASAL FENTANYL ON POSTANESTHETIC BEHAVIOR IN CHILDREN$0
M01 · FY2002 · RR
EFFECT OF NASAL FENTANYL ON POSTANESTHETIC BEHAVIOR IN CHILDREN$560
M01 · FY2000 · RR